BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 46.75 Million USD | -22.76% |
| 2022 | 53.82 Million USD | 42.58% |
| 2021 | 37.74 Million USD | 37.56% |
| 2020 | 27.44 Million USD | 48.23% |
| 2019 | 18.51 Million USD | 36.88% |
| 2018 | 13.52 Million USD | 100.49% |
| 2017 | 6.74 Million USD | 41.16% |
| 2016 | 4.77 Million USD | 25.29% |
| 2015 | 3.81 Million USD | 25.66% |
| 2014 | 3.03 Million USD | -19.33% |
| 2013 | 3.76 Million USD | 64.14% |
| 2012 | 2.29 Million USD | 63.38% |
| 2011 | 1.4 Million USD | 63.85% |
| 2010 | 856.38 Thousand USD | 49.05% |
| 2009 | 574.57 Thousand USD | 4.12% |
| 2008 | 551.85 Thousand USD | 8.39% |
| 2007 | 509.15 Thousand USD | 66.85% |
| 2006 | 305.15 Thousand USD | -16.31% |
| 2005 | 364.64 Thousand USD | -21.2% |
| 2004 | 462.73 Thousand USD | -23.58% |
| 2003 | 605.51 Thousand USD | -28.66% |
| 2002 | 848.79 Thousand USD | 52.85% |
| 2001 | 555.31 Thousand USD | -39.68% |
| 2000 | 920.54 Thousand USD | -16.0% |
| 1999 | 1.09 Million USD | 0.2% |
| 1998 | 1.09 Million USD | -33.83% |
| 1997 | 1.65 Million USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 7.83 Million USD | 18.67% |
| 1994 | 6.6 Million USD | 450.0% |
| 1993 | 1.2 Million USD | 146.15% |
| 1992 | -2.6 Million USD | -136.36% |
| 1991 | -1.1 Million USD | -57.14% |
| 1990 | -700 Thousand USD | -600.0% |
| 1989 | -100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.64 Million USD | 39.72% |
| 2024 Q2 | 13.98 Million USD | 27.87% |
| 2023 Q1 | 14.03 Million USD | 0.48% |
| 2023 FY | 41.57 Million USD | -22.76% |
| 2023 Q2 | 11.81 Million USD | -15.86% |
| 2023 Q4 | 8.33 Million USD | -28.44% |
| 2023 Q3 | 11.64 Million USD | -1.38% |
| 2022 FY | 53.82 Million USD | 42.58% |
| 2022 Q1 | 11.77 Million USD | 71.53% |
| 2022 Q2 | 14.33 Million USD | 21.79% |
| 2022 Q3 | 13.73 Million USD | -4.19% |
| 2022 Q4 | 13.97 Million USD | 1.7% |
| 2021 FY | 37.74 Million USD | 37.56% |
| 2021 Q3 | 8.93 Million USD | -29.36% |
| 2021 Q2 | 12.65 Million USD | 36.07% |
| 2021 Q4 | 6.86 Million USD | -23.19% |
| 2021 Q1 | 9.29 Million USD | 16.61% |
| 2020 Q1 | 7.59 Million USD | 48.09% |
| 2020 Q3 | 6.45 Million USD | 19.04% |
| 2020 Q4 | 7.97 Million USD | 23.55% |
| 2020 FY | 27.44 Million USD | 48.23% |
| 2020 Q2 | 5.42 Million USD | -28.61% |
| 2019 Q4 | 5.12 Million USD | 13.45% |
| 2019 Q1 | 4.12 Million USD | 10.06% |
| 2019 Q2 | 4.74 Million USD | 15.04% |
| 2019 FY | 18.51 Million USD | 36.88% |
| 2019 Q3 | 4.52 Million USD | -4.7% |
| 2018 Q1 | 2.45 Million USD | 33.21% |
| 2018 FY | 13.52 Million USD | 100.49% |
| 2018 Q4 | 3.74 Million USD | 1.61% |
| 2018 Q3 | 3.68 Million USD | 1.26% |
| 2018 Q2 | 3.64 Million USD | 48.55% |
| 2017 Q1 | 1.43 Million USD | 5.26% |
| 2017 Q2 | 1.6 Million USD | 11.35% |
| 2017 FY | 6.74 Million USD | 41.16% |
| 2017 Q4 | 1.84 Million USD | -1.48% |
| 2017 Q3 | 1.86 Million USD | 16.66% |
| 2016 Q3 | 1.21 Million USD | 8.69% |
| 2016 Q2 | 1.11 Million USD | 3.34% |
| 2016 Q1 | 1.08 Million USD | -5.14% |
| 2016 FY | 4.77 Million USD | 25.29% |
| 2016 Q4 | 1.36 Million USD | 12.5% |
| 2015 Q3 | 973.38 Thousand USD | 18.9% |
| 2015 Q2 | 818.64 Thousand USD | -7.25% |
| 2015 Q4 | 1.13 Million USD | 17.07% |
| 2015 FY | 3.81 Million USD | 25.66% |
| 2015 Q1 | 882.62 Thousand USD | -11.59% |
| 2014 FY | 3.03 Million USD | -19.33% |
| 2014 Q4 | 998.3 Thousand USD | 69.67% |
| 2014 Q3 | 588.39 Thousand USD | 7.9% |
| 2014 Q2 | 545.32 Thousand USD | -39.64% |
| 2014 Q1 | 903.38 Thousand USD | -1.82% |
| 2013 Q2 | 828.44 Thousand USD | -26.39% |
| 2013 Q3 | 888.85 Thousand USD | 7.29% |
| 2013 Q4 | 920.1 Thousand USD | 3.52% |
| 2013 FY | 3.76 Million USD | 64.14% |
| 2013 Q1 | 1.12 Million USD | 49.75% |
| 2012 Q4 | 751.55 Thousand USD | 26.22% |
| 2012 Q3 | 595.44 Thousand USD | 30.68% |
| 2012 Q1 | 489.75 Thousand USD | 7.15% |
| 2012 Q2 | 455.66 Thousand USD | -6.96% |
| 2012 FY | 2.29 Million USD | 63.38% |
| 2011 Q4 | 457.06 Thousand USD | 23.54% |
| 2011 Q2 | 333.93 Thousand USD | 37.88% |
| 2011 Q1 | 242.19 Thousand USD | 16.85% |
| 2011 Q3 | 369.96 Thousand USD | 10.79% |
| 2011 FY | 1.4 Million USD | 63.85% |
| 2010 FY | 856.38 Thousand USD | 49.05% |
| 2010 Q4 | 207.27 Thousand USD | -7.82% |
| 2010 Q3 | 224.84 Thousand USD | 16.13% |
| 2010 Q2 | 193.61 Thousand USD | -18.89% |
| 2010 Q1 | 238.72 Thousand USD | -5.36% |
| 2009 Q1 | 146.83 Thousand USD | -12.56% |
| 2009 Q3 | 117.81 Thousand USD | 104.27% |
| 2009 Q2 | 57.67 Thousand USD | -60.72% |
| 2009 Q4 | 252.25 Thousand USD | 114.11% |
| 2009 FY | 574.57 Thousand USD | 4.12% |
| 2008 FY | 551.85 Thousand USD | 8.39% |
| 2008 Q2 | 50.6 Thousand USD | -68.22% |
| 2008 Q4 | 167.91 Thousand USD | -3.55% |
| 2008 Q1 | 159.23 Thousand USD | 47.42% |
| 2008 Q3 | 174.1 Thousand USD | 244.06% |
| 2007 Q3 | 166.49 Thousand USD | 29.39% |
| 2007 Q1 | 105.96 Thousand USD | -4.05% |
| 2007 Q2 | 128.68 Thousand USD | 21.43% |
| 2007 Q4 | 108.01 Thousand USD | -35.13% |
| 2007 FY | 509.15 Thousand USD | 66.85% |
| 2006 Q3 | 64.61 Thousand USD | 0.55% |
| 2006 Q4 | 110.44 Thousand USD | 70.92% |
| 2006 FY | 305.15 Thousand USD | -16.31% |
| 2006 Q1 | 65.82 Thousand USD | -22.58% |
| 2006 Q2 | 64.26 Thousand USD | -2.37% |
| 2005 Q1 | 71.58 Thousand USD | 2561.3% |
| 2005 Q2 | 39.16 Thousand USD | -45.29% |
| 2005 Q3 | 110.14 Thousand USD | 181.26% |
| 2005 Q4 | 85.02 Thousand USD | -22.81% |
| 2005 FY | 364.64 Thousand USD | -21.2% |
| 2004 Q2 | 137.4 Thousand USD | -16.3% |
| 2004 FY | 462.73 Thousand USD | -23.58% |
| 2004 Q4 | 2690.00 USD | -98.19% |
| 2004 Q3 | 148.92 Thousand USD | 8.39% |
| 2004 Q1 | 164.15 Thousand USD | 82.51% |
| 2003 Q4 | 89.94 Thousand USD | -47.38% |
| 2003 FY | 605.51 Thousand USD | -28.66% |
| 2003 Q1 | 228.28 Thousand USD | -31.24% |
| 2003 Q2 | 104.03 Thousand USD | -54.43% |
| 2003 Q3 | 170.92 Thousand USD | 64.3% |
| 2002 FY | 848.79 Thousand USD | 52.85% |
| 2002 Q1 | 220.54 Thousand USD | 907.25% |
| 2002 Q3 | 138 Thousand USD | 87.92% |
| 2002 Q2 | 73.44 Thousand USD | -66.7% |
| 2002 Q4 | 331.97 Thousand USD | 140.55% |
| 2001 Q1 | 273.71 Thousand USD | -3.03% |
| 2001 FY | 555.31 Thousand USD | -39.68% |
| 2001 Q4 | 21.89 Thousand USD | -86.15% |
| 2001 Q3 | 158.12 Thousand USD | -2.03% |
| 2001 Q2 | 161.39 Thousand USD | -41.03% |
| 2000 Q1 | 332.08 Thousand USD | -16.98% |
| 2000 Q4 | 282.25 Thousand USD | 92.79% |
| 2000 Q3 | 146.4 Thousand USD | -8.38% |
| 2000 Q2 | 159.8 Thousand USD | -51.88% |
| 2000 FY | 920.54 Thousand USD | -16.0% |
| 1999 Q1 | 90 Thousand USD | 143.61% |
| 1999 Q3 | 120 Thousand USD | -42.86% |
| 1999 Q4 | 400 Thousand USD | 233.33% |
| 1999 FY | 1.09 Million USD | 0.2% |
| 1999 Q2 | 210 Thousand USD | 133.33% |
| 1998 Q4 | -206.39 Thousand USD | -151.6% |
| 1998 Q1 | 300 Thousand USD | 18.68% |
| 1998 Q2 | 500 Thousand USD | 66.67% |
| 1998 Q3 | 400 Thousand USD | -20.0% |
| 1998 FY | 1.09 Million USD | -33.83% |
| 1997 FY | 1.65 Million USD | 0.0% |
| 1997 Q1 | 800 Thousand USD | 0.0% |
| 1997 Q3 | 400 Thousand USD | 33.33% |
| 1997 Q4 | 252.78 Thousand USD | -36.8% |
| 1997 Q2 | 300 Thousand USD | -62.5% |
| 1996 Q3 | 600 Thousand USD | 372.51% |
| 1996 Q1 | 1.2 Million USD | 9.09% |
| 1996 Q2 | -220.17 Thousand USD | -118.35% |
| 1996 FY | - USD | -100.0% |
| 1995 Q3 | 1.2 Million USD | -26.48% |
| 1995 FY | 7.83 Million USD | 18.67% |
| 1995 Q1 | 2 Million USD | -56.52% |
| 1995 Q4 | 1.1 Million USD | -8.33% |
| 1995 Q2 | 1.63 Million USD | -18.39% |
| 1994 Q2 | 2 Million USD | 42.86% |
| 1994 Q3 | 1.8 Million USD | -10.0% |
| 1994 Q1 | 1.4 Million USD | -26.32% |
| 1994 FY | 6.6 Million USD | 450.0% |
| 1994 Q4 | 4.6 Million USD | 155.56% |
| 1993 FY | 1.2 Million USD | 146.15% |
| 1993 Q4 | 1.9 Million USD | 35.71% |
| 1993 Q3 | 1.4 Million USD | 16.67% |
| 1993 Q2 | 1.2 Million USD | 140.0% |
| 1993 Q1 | 500 Thousand USD | 350.0% |
| 1992 Q2 | - USD | -100.0% |
| 1992 FY | -2.6 Million USD | -136.36% |
| 1992 Q4 | -200 Thousand USD | 33.33% |
| 1992 Q3 | -300 Thousand USD | 0.0% |
| 1992 Q1 | 100 Thousand USD | 114.29% |
| 1991 Q4 | -700 Thousand USD | -800.0% |
| 1991 FY | -1.1 Million USD | -57.14% |
| 1991 Q2 | - USD | -100.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q3 | -400 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 125.0% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 FY | -700 Thousand USD | -600.0% |
| 1990 Q2 | - USD | -100.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | -100 Thousand USD | 0.0% |
| 1989 Q4 | 100 Thousand USD | 0.0% |
| 1989 Q3 | 100 Thousand USD | 0.0% |
| 1989 Q2 | - USD | -100.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 16.967% |
| AngioDynamics, Inc. | 154.69 Million USD | 69.779% |
| AtriCure, Inc. | 300.37 Million USD | 84.435% |
| Avinger, Inc. | 2 Million USD | -2234.099% |
| Azenta, Inc. | 263.14 Million USD | 82.233% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 98.017% |
| Daxor Corporation | 1.1 Million USD | -4136.932% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -414.947% |
| Femasys Inc. | 691.9 Thousand USD | -6657.036% |
| GlucoTrack, Inc. | -13 Thousand USD | 359730.769% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 23.189% |
| Hologic, Inc. | 2.22 Billion USD | 97.901% |
| ICU Medical, Inc. | 739.87 Million USD | 93.681% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.011% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -179.813% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 63.202% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 39279.076% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 39279.076% |
| Masimo Corporation | 1 Billion USD | 95.341% |
| Microbot Medical Inc. | -106 Thousand USD | 44205.66% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -41.266% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 91.993% |
| Nephros, Inc. | 8.4 Million USD | -456.24% |
| NovoCure Limited | 381.05 Million USD | 87.731% |
| NEXGEL, Inc. | 619 Thousand USD | -7452.827% |
| NEXGEL, Inc. | 619 Thousand USD | -7452.827% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 8478.495% |
| OraSure Technologies, Inc. | 179.42 Million USD | 73.943% |
| Pro-Dex, Inc. | 14.55 Million USD | -221.298% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 3973.405% |
| Predictive Oncology Inc. | 1.14 Million USD | -3982.085% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -706.378% |
| QuidelOrtho Corporation | 1.49 Billion USD | 96.872% |
| Repligen Corporation | 315.22 Million USD | 85.169% |
| Sanara MedTech Inc. | 57.13 Million USD | 18.176% |
| STAAR Surgical Company | 252.65 Million USD | 81.495% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 5345.678% |
| Utah Medical Products, Inc. | 30.03 Million USD | -55.643% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 97.759% |
| Jin Medical International Ltd. | 6.78 Million USD | -589.066% |